学术任务
日期 | 时间 | 会场 | 类型 | Session/单元 | 题目 |
2025-06-14 | 17:00-17:08 | 分会场十(【B座-5层-501C】) | 专题发言 | Session V 风华正茂 锐意进取 | Enfortumab Vedotin Plus Pembrolizumab (EV+P) Vs Chemotherapy (Chemo) in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC): Pan-Asian Subgroup Analysis From EV-302/KEYNOTE-A39 |